IQVIA outlook for 2026 improved on October 27, when the life sciences services company raised its full-year revenue and adjusted earnings guidance alongside its third-quarter results.

IQVIA outlook for the full year

IQVIA now expects adjusted earnings of $12.90 to $13.00 per share for fiscal 2026, compared with its previous forecast of $12.80 to $13.00. The revision raises the bottom of the range while leaving the top unchanged.

The company also projects revenue of $17.35 billion to $17.50 billion, up from its earlier range of $17.275 billion to $17.475 billion. Both ends of the revenue range increased.

The figures are company forecasts, not completed full-year results. IQVIA announced the updated guidance as it reported third-quarter financial results.

Shares rise in premarket trading

IQVIA shares traded at $280.00 in premarket trading on October 27, up $6.40, or 2.34%. The stock is listed on the New York Stock Exchange under the ticker IQV.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.